Large gap with delayed quotes
|
Last quote
09/16/2026
-
23:20:00
|
Bid
09/16/2026 -
21:59:54
|
Bid Volume |
Ask
09/16/2026 -
21:59:54
|
Ask Volume |
|---|---|---|---|---|
|
72.33
-0.01
(
-0.01% )
|
72.34
|
900 |
72.35
|
3,000 |
Analysis date: 15.09.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 24.04.2026.
Quality
Strong
Strong
Three stars since 08.09.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 07.07.2026 at a price of 70.61.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 05.06.2026.
4wk Rel Perf
2.60%
2.60%
The four-week dividend-adjusted overperformance versus SP500 is 2.60%.
Risk
High
High
The stock has been on the high-sensitivity level since 24.04.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.73%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.90%.
Mkt Cap in $bn
11.33
11.33
With a market capitalization >$8bn, BIO-TECHNE is considered a large-cap stock.
G/PE Ratio
0.71
0.71
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
31.45
31.45
The estimated PE is for the year 2028.
LT Growth
21.79%
21.79%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
10
10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
0.44%
0.44%
The twelve month estimated dividend yield represents 13.91% of earnings forecasts.
Beta
63
63
For 1% of index variation, the stock varies on average by 0.63%.
Correlation
0.16
0.16
Stock movements are totally independent of index variations.
Value at Risk
28.10
28.10
The value at risk is estimated at USD 28.10. The risk is therefore 38.85%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004